Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Celgene in additional $5 Billion share repurchase
February 14, 2018 Off

Celgene in additional $5 Billion share repurchase

By Dino Mustafić

Celgene Corporation has authorized the repurchase of an additional $5 billion of its common stock. As the company noted, the…

Novartis forms alliance to develop medicines for treating infectious diarrheal disease
February 14, 2018 Off

Novartis forms alliance to develop medicines for treating infectious diarrheal disease

By Dino Mustafić

Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance development of Novartis’ drug candidate KDU731…

Lilly’s Taltz meets enpoints in phase 3 study of Taltz for treating painful spine due to radiographic axial spondyloarthritis
February 13, 2018 Off

Lilly’s Taltz meets enpoints in phase 3 study of Taltz for treating painful spine due to radiographic axial spondyloarthritis

By Dino Mustafić

Eli Lilly said on Tuesday that its Ankylosing Spondylitis treatment candidate, Taltz met the primary and all key secondary endpoints…

Vertex offers Symdeko for more cystic fibrosis patients
February 13, 2018 Off

Vertex offers Symdeko for more cystic fibrosis patients

By Dino Mustafić

Vertex Pharmaceuticals Incorporated can now offer Symdeko for treating the underlying cause of cystic fibrosis (CF) for more certain patients.…

February 13, 2018 Off

BD with pre-market approval from FDA for BD Onclarity HPV assay

By Dino Mustafić

BD has received pre-market approval from the U.S. Food and Drug Administration for the BD Onclarity HPV assay, the company…

Actinium seeks chance to maximize value for partners and collaborators, applies Acute Myeloid Leukemia treatment for investigation
February 12, 2018 Off

Actinium seeks chance to maximize value for partners and collaborators, applies Acute Myeloid Leukemia treatment for investigation

By Dino Mustafić

Actinium Pharmaceuticals has applied an Investigational New Drug for Actimab-A combined with CLAG-M, for Acute Myeloid Leukemia, to the USFDA.

Audent Therapeutics starts dosing patients for rare pediatric disease Crigler-Najjar Syndrome, as it tests recently fast tracked AT342
February 12, 2018 Off

Audent Therapeutics starts dosing patients for rare pediatric disease Crigler-Najjar Syndrome, as it tests recently fast tracked AT342

By Dino Mustafić

Audentes Therapeutics has started with dosing of patients in a Phase 1/2 clinical trial of its product candidate AT342 for…

Santen’s has potential treatment for patients with wet AMD
February 12, 2018 Off

Santen’s has potential treatment for patients with wet AMD

By Dino Mustafić

Santen’s topline results from the Phase I/II study of DE-122 for refractory wet age-related macular degeneration (AMD) suggest bioactivity of DE-122…

February 12, 2018 Off

Bardoxolone methyl improves kidney functions for pulmonary arterial hypertension patients, Reata study suggests

By Dino Mustafić

Reata Pharmaceuticals has reported that its study that shows bardoxolone methyl can improve kidney functions for patients with pulmonary arterial…

ImmunoMet appoints two new executives
February 12, 2018 Off

ImmunoMet appoints two new executives

By Dino Mustafić

ImmunoMet Therapeutics, a private US-based biotechnology company, on Monday appointed two new executives, for medical and financial departments.

Posts pagination

Previous 1 … 3,405 3,406 3,407 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine